Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis
John Kanellis(The University of Melbourne), David Sheikh‐Hamad(Michael E. DeBakey VA Medical Center), Brian J. Poindexter(The University of Texas Health Science Center at Houston), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Lili Feng(The University of Texas Health Science Center at Houston), Gabriela García(University of Colorado Denver), Luan D. Truong, Richard J. Johnson(VA Eastern Colorado Health Care System), Roger J. Bick(The University of Texas Health Science Center at Houston), Chun C. Tsao(Baylor College of Medicine)
Cited by 81
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2
|Hypertension|2003|790
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
|Diabetes|2013|735
Uric acid and chronic kidney disease: which is chasing which?
|Nephrology Dialysis Transplantation|2013|644